148 related articles for article (PubMed ID: 31465596)
41. Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Donigan JM; Hyde MA; Goldgar DE; Hadley ML; Bowling M; Bowen GM
JAMA Dermatol; 2018 Aug; 154(8):885-889. PubMed ID: 29847610
[TBL] [Abstract][Full Text] [Related]
42. [Dubreuilh melanoma(lentigo maligna melanoma)].
Ollivaud L; Basset-Seguin N; Archimbaud A
Ann Dermatol Venereol; 2001 Feb; 128(2):172-6. PubMed ID: 11275603
[No Abstract] [Full Text] [Related]
43. A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
Fleming CJ; Bryden AM; Evans A; Dawe RS; Ibbotson SH
Br J Dermatol; 2004 Aug; 151(2):485-8. PubMed ID: 15327559
[TBL] [Abstract][Full Text] [Related]
44. Lentigo maligna melanoma--the review.
Situm M; Bolanca Z; Buljan M
Coll Antropol; 2010 Apr; 34 Suppl 2():299-301. PubMed ID: 21305747
[TBL] [Abstract][Full Text] [Related]
45. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
Arlette JP; Trotter MJ; Trotter T; Temple CL
J Surg Oncol; 2004 Jul; 86(4):179-86. PubMed ID: 15221924
[TBL] [Abstract][Full Text] [Related]
46. Locally Recurrent Lentigo Maligna and Lentigo Maligna Melanoma: Characteristics and Time to Recurrence After Surgery.
Connolly KL; Hibler BP; Lee EH; Rossi AM; Busam KJ; Nehal KS
Dermatol Surg; 2017 Jun; 43(6):792-797. PubMed ID: 28296789
[TBL] [Abstract][Full Text] [Related]
47. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients.
Schmid-Wendtner MH; Brunner B; Konz B; Kaudewitz P; Wendtner CM; Peter RU; Plewig G; Volkenandt M
J Am Acad Dermatol; 2000 Sep; 43(3):477-82. PubMed ID: 10954659
[TBL] [Abstract][Full Text] [Related]
48. Lentigo maligna: diagnosis and treatment.
Bosbous MW; Dzwierzynski WW; Neuburg M
Clin Plast Surg; 2010 Jan; 37(1):35-46. PubMed ID: 19914456
[TBL] [Abstract][Full Text] [Related]
49. Johnson square procedure for lentigo maligna and lentigo maligna melanoma.
Patel AN; Perkins W; Leach IH; Varma S
Clin Exp Dermatol; 2014 Jul; 39(5):570-6. PubMed ID: 24934910
[TBL] [Abstract][Full Text] [Related]
50. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays.
Farshad A; Burg G; Panizzon R; Dummer R
Br J Dermatol; 2002 Jun; 146(6):1042-6. PubMed ID: 12072074
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial.
Choi SH; Kim KH; Song KH
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1598-605. PubMed ID: 25640401
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections.
Cohen LM; McCall MW; Hodge SJ; Freedman JD; Callen JP; Zax RH
Cancer; 1994 Jun; 73(12):2964-70. PubMed ID: 8199993
[TBL] [Abstract][Full Text] [Related]
53. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy.
Karrer S; Szeimies RM; Hohenleutner U; Landthaler M
Am J Clin Dermatol; 2001; 2(4):229-37. PubMed ID: 11705250
[TBL] [Abstract][Full Text] [Related]
54. Treatment of lentigo maligna.
Carucci JA
Cutis; 2001 May; 67(5):389-92. PubMed ID: 11381854
[TBL] [Abstract][Full Text] [Related]
55. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
[TBL] [Abstract][Full Text] [Related]
56. Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas--a randomized clinical trial.
Haak CS; Togsverd-Bo K; Thaysen-Petersen D; Wulf HC; Paasch U; Anderson RR; Haedersdal M
Br J Dermatol; 2015 Jan; 172(1):215-22. PubMed ID: 24903544
[TBL] [Abstract][Full Text] [Related]
57. Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia.
Matas-Nadal C; Malvehy J; Ferreres JR; Boada A; Bodet D; Segura S; Salleras M; Azon A; Bel-Pla S; Bigata X; Campoy A; Curcó N; Dalmau J; Formigon M; Gonzalez A; Just M; Llistosella E; Nogues ME; Pedragosa R; Pujol JA; Sabat M; Smandia JA; Zaballos P; Puig S; Martí RM
Int J Dermatol; 2019 May; 58(5):577-581. PubMed ID: 30548854
[TBL] [Abstract][Full Text] [Related]
58. Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: A randomized, controlled pilot study.
Yao Y; Shi L; Wang Y; Shen X; Ye S; Tang G; Wu L
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102523. PubMed ID: 34487871
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic and therapeutic techniques in lentigo maligna: an update.
Collgros H; Lamas-Doménech N
Actas Dermosifiliogr; 2015 Mar; 106(2):135-6. PubMed ID: 25439146
[No Abstract] [Full Text] [Related]
60. Enhanced efficacy of photodynamic therapy after fractional resurfacing: fractional photodynamic rejuvenation.
Ruiz-Rodriguez R; López L; Candelas D; Zelickson B
J Drugs Dermatol; 2007 Aug; 6(8):818-20. PubMed ID: 17763613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
